INVO Fertility (IVF) Cash from Financing Activities (2011 - 2026)
INVO Fertility (IVF) posted quarterly Cash from Financing Activities of $5.0 million for Q1 2026, up 35.36% year-over-year from $3.7 million in Q1 2025, and up 211.27% quarter-over-quarter from $1.6 million in Q3 2025.
INVO Fertility (IVF) Cash from Financing Activities (2011 - 2026) Analysis & Trends
INVO Fertility (IVF) has reported Cash from Financing Activities for 15 consecutive years, with $5.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 35.36% year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $11.6 million (up 86.29% YoY), while the FY2024 annual figure was $3.1 million, down 57.8% from the prior year.
- Cash from Financing Activities advanced to $5.0 million in Q1 2026 per IVF's latest filing, from $1.6 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $5.0 million in Q1 2026 and bottomed at -$169856.0 in Q2 2023.
- Historically, Cash from Financing Activities has averaged $1.5 million across 5 years, with a median of $800000.0 in 2022.
- On a YoY basis, Cash from Financing Activities climbed as much as 17753.12% in 2023 and fell as far as 117.69% in 2023.
- INVO Fertility's Cash from Financing Activities stood at $800000.0 in 2022, then slumped by 117.69% to -$141527.0 in 2023, then soared by 449.09% to $494050.0 in 2024, then soared by 222.09% to $1.6 million in 2025, then jumped by 211.27% to $5.0 million in 2026.
- Business Quant data shows IVF's Cash from Financing Activities at $5.0 million in Q1 2026, $1.6 million in Q3 2025, and $1.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -213.50 Mn |
| 10 | INVO Fertility | 2.24 Mn | 2.24 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.95 Mn |
| Mar 31, 2026 | 4.95 Mn |
| Sep 30, 2025 | 1.59 Mn |
| Sep 30, 2025 | 1.59 Mn |
| Jun 30, 2025 | 1.44 Mn |
| Jun 30, 2025 | 1.44 Mn |
| Mar 31, 2025 | 3.66 Mn |
| Mar 31, 2025 | 3.66 Mn |
| Dec 31, 2024 | 494,050.00 |
| Dec 31, 2024 | 494,050.00 |
| Sep 30, 2024 | 169,464.00 |
| Sep 30, 2024 | 169,464.00 |
| Jun 30, 2024 | 1.93 Mn |
| Jun 30, 2024 | 1.93 Mn |
| Mar 31, 2024 | 527,366.00 |
| Mar 31, 2024 | 527,366.00 |
| Dec 31, 2023 | -141,527.00 |
| Dec 31, 2023 | -141,527.00 |
| Sep 30, 2023 | 4.45 Mn |
| Sep 30, 2023 | 4.45 Mn |